GLAUKOS Corp Insider Trading for March 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in GLAUKOS Corp.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in GLAUKOS Corp for March 2018.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 16 2018 | GKOS | GLAUKOS Corp | Burns Thomas William | Chief Executive Off ... | Option Exercise | A | 30.92 | 266,000 | 8,224,720 | 266,000 | |
Mar 16 2018 | GKOS | GLAUKOS Corp | Calcaterra Chris M. | Chief Operating Off ... | Option Exercise | A | 30.92 | 80,500 | 2,489,060 | 80,500 | |
Mar 16 2018 | GKOS | GLAUKOS Corp | Gilliam Joseph E | CFO, SVP Corporate ... | Option Exercise | A | 30.92 | 80,500 | 2,489,060 | 80,500 | |
Mar 06 2018 | GKOS | GLAUKOS Corp | SILVERSTEIN JONATHAN | Director | Sell | S | 32.06 | 445 | 14,267 | 0 | 445 to 0 (-100.00 %) |
Mar 06 2018 | GKOS | GLAUKOS Corp | SILVERSTEIN JONATHAN | Director | Sell | S | 32.06 | 46,676 | 1,496,433 | 0 | 46.7 K to 0 (-100.00 %) |
Mar 06 2018 | GKOS | GLAUKOS Corp | SILVERSTEIN JONATHAN | Director | Sell | S | 30.77 | 192 | 5,908 | 445 | 637 to 445 (-30.14 %) |
Mar 06 2018 | GKOS | GLAUKOS Corp | SILVERSTEIN JONATHAN | Director | Sell | S | 30.77 | 20,114 | 618,908 | 46,676 | 66.8 K to 46.7 K (-30.12 %) |
Mar 06 2018 | GKOS | GLAUKOS Corp | SILVERSTEIN JONATHAN | Director | Sell | S | 30.01 | 886 | 26,589 | 637 | 1.5 K to 637 (-58.17 %) |
Mar 06 2018 | GKOS | GLAUKOS Corp | SILVERSTEIN JONATHAN | Director | Sell | S | 30.01 | 93,008 | 2,791,170 | 66,790 | 159.8 K to 66.8 K (-58.20 %) |
Mar 06 2018 | GKOS | GLAUKOS Corp | SILVERSTEIN JONATHAN | Director | Sell | S | 33.06 | 768 | 25,390 | 1,523 | 2.3 K to 1.5 K (-33.52 %) |
Mar 06 2018 | GKOS | GLAUKOS Corp | SILVERSTEIN JONATHAN | Director | Sell | S | 33.06 | 80,516 | 2,661,859 | 159,798 | 240.3 K to 159.8 K (-33.50 %) |
Mar 06 2018 | GKOS | GLAUKOS Corp | SILVERSTEIN JONATHAN | Director | Sell | S | 32.05 | 1,220 | 39,101 | 2,291 | 3.5 K to 2.3 K (-34.75 %) |
Mar 06 2018 | GKOS | GLAUKOS Corp | SILVERSTEIN JONATHAN | Director | Sell | S | 32.05 | 128,092 | 4,105,349 | 240,314 | 368.4 K to 240.3 K (-34.77 %) |
Mar 06 2018 | GKOS | GLAUKOS Corp | SILVERSTEIN JONATHAN | Director | Sell | S | 32.80 | 1,851 | 60,713 | 3,511 | 5.4 K to 3.5 K (-34.52 %) |
Mar 06 2018 | GKOS | GLAUKOS Corp | SILVERSTEIN JONATHAN | Director | Sell | S | 32.80 | 194,433 | 6,377,402 | 368,406 | 562.8 K to 368.4 K (-34.55 %) |
Mar 06 2018 | GKOS | GLAUKOS Corp | SILVERSTEIN JONATHAN | Director | Sell | S | 31.92 | 2,533 | 80,853 | 5,362 | 7.9 K to 5.4 K (-32.08 %) |
Mar 06 2018 | GKOS | GLAUKOS Corp | SILVERSTEIN JONATHAN | Director | Sell | S | 31.92 | 265,766 | 8,483,251 | 562,839 | 828.6 K to 562.8 K (-32.07 %) |
Mar 06 2018 | GKOS | GLAUKOS Corp | ORBIMED ADVISORS LLC | Director | Sell | S | 32.06 | 445 | 14,267 | 0 | 445 to 0 (-100.00 %) |
Mar 06 2018 | GKOS | GLAUKOS Corp | ORBIMED ADVISORS LLC | Director | Sell | S | 32.06 | 46,676 | 1,496,433 | 0 | 46.7 K to 0 (-100.00 %) |
Mar 06 2018 | GKOS | GLAUKOS Corp | ORBIMED ADVISORS LLC | Director | Sell | S | 30.77 | 192 | 5,908 | 445 | 637 to 445 (-30.14 %) |
Mar 06 2018 | GKOS | GLAUKOS Corp | ORBIMED ADVISORS LLC | Director | Sell | S | 30.77 | 20,114 | 618,908 | 46,676 | 66.8 K to 46.7 K (-30.12 %) |
Mar 06 2018 | GKOS | GLAUKOS Corp | ORBIMED ADVISORS LLC | Director | Sell | S | 30.01 | 886 | 26,589 | 637 | 1.5 K to 637 (-58.17 %) |
Mar 06 2018 | GKOS | GLAUKOS Corp | ORBIMED ADVISORS LLC | Director | Sell | S | 30.01 | 93,008 | 2,791,170 | 66,790 | 159.8 K to 66.8 K (-58.20 %) |
Mar 06 2018 | GKOS | GLAUKOS Corp | ORBIMED ADVISORS LLC | Director | Sell | S | 33.06 | 768 | 25,390 | 1,523 | 2.3 K to 1.5 K (-33.52 %) |
Mar 06 2018 | GKOS | GLAUKOS Corp | ORBIMED ADVISORS LLC | Director | Sell | S | 33.06 | 80,516 | 2,661,859 | 159,798 | 240.3 K to 159.8 K (-33.50 %) |
Mar 06 2018 | GKOS | GLAUKOS Corp | ORBIMED ADVISORS LLC | Director | Sell | S | 32.05 | 1,220 | 39,101 | 2,291 | 3.5 K to 2.3 K (-34.75 %) |
Mar 06 2018 | GKOS | GLAUKOS Corp | ORBIMED ADVISORS LLC | Director | Sell | S | 32.05 | 128,092 | 4,105,349 | 240,314 | 368.4 K to 240.3 K (-34.77 %) |
Mar 06 2018 | GKOS | GLAUKOS Corp | ORBIMED ADVISORS LLC | Director | Sell | S | 32.80 | 1,851 | 60,713 | 3,511 | 5.4 K to 3.5 K (-34.52 %) |
Mar 06 2018 | GKOS | GLAUKOS Corp | ORBIMED ADVISORS LLC | Director | Sell | S | 32.80 | 194,433 | 6,377,402 | 368,406 | 562.8 K to 368.4 K (-34.55 %) |
Mar 06 2018 | GKOS | GLAUKOS Corp | ORBIMED ADVISORS LLC | Director | Sell | S | 31.92 | 2,533 | 80,853 | 5,362 | 7.9 K to 5.4 K (-32.08 %) |
Mar 06 2018 | GKOS | GLAUKOS Corp | ORBIMED ADVISORS LLC | Director | Sell | S | 31.92 | 265,766 | 8,483,251 | 562,839 | 828.6 K to 562.8 K (-32.07 %) |